CCL2 and ischemic stroke: Following an ischemic stroke episode, dBET1 administration to mice significantly reduces the expression level of CCL2, which in turn attenuates ischemia-induced microglia and astrocyte-reactive gliosis and improves prognosis (Liu et al., 2022).